Veraxa Biotech shares are trading higher after the company announced the initiation of cell line development for its lead BiTAC T-cell engag
Veraxa Biotech shares are trading higher after the company announced the initiation of cell line development for its lead BiTAC T-cell engager program.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.